This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Basic Focus Stack

Community Protocol

Beginner Nootropic Stack / Sustained Attention / Mental Clarity / Calm Productivity

TYPICAL DOSE
CDP-Choline 250-500 mg AM; Aniracetam 750-1500 mg with fat; Oxiracetam 750-1500 mg AM; Caffeine 100 mg + L-Theanine 200 mg (1:2 ratio)
ROUTE
CYCLE
STORAGE

Overview

What is Basic Focus Stack?

Scientific Sean's beginner-friendly 'BASIC starter Nootropic stack for FOCUS' — a four-component foundational protocol combining a cholinergic precursor (CDP-Choline), two complementary racetams (Aniracetam + Oxiracetam), and the classic caffeine + L-theanine combo. Designed as the entry point before researchers escalate to harsher stimulants or stronger compounds. Targets cognitive stability over acute stimulation.

Key Benefits

Mental clarity, sustained attention, information retention, task endurance, cognitive stability, and reduced mental fatigue — without the 'wired' or 'electrocuted' feeling of stimulant-heavy stacks. Sean frames this as creating a 'solid, beginner-friendly, stable cognitive foundation' rather than masking baseline deficits in sleep, stress, hydration, or dopamine tone.

Mechanism of Action

Four-vector cognitive support: (1) CDP-Choline raises choline availability for acetylcholine synthesis + supports phospholipid membrane repair and dopamine function; (2) Aniracetam positively modulates AMPA receptors with anxiolytic + mood-enhancing effects; (3) Oxiracetam modulates cholinergic + glutamatergic signaling for processing speed and logical thinking; (4) Caffeine antagonizes adenosine for wakefulness while L-theanine smooths excessive stimulation and increases relaxed alpha-brain-wave activity. Net effect: clean, calm sustained attention without jitter.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources